Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Beigene ADS Representing Ord Shs BGNE

Healthcare Biotechnology
BeiGene, Ltd. is a global biotechnology company engaged in discovering and developing oncology treatments for cancer patients worldwide. The Company has discovered and developed three approved medicines, including BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of various blood cancers; TEVIMBRA (tislelizumab), an anti-PD-1 antibody immunotherapy for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BGNE)

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

PR Newswire 3 days ago

BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA

Business Wire 3 days ago

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

Business Wire 8 days ago

BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates

Business Wire 10 days ago

BeiGene to Present at the Jefferies London Healthcare Conference

Business Wire November 6, 2024

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

Business Wire November 5, 2024

BeiGene Mourns Death of Beloved Board Member Donald Glazer

Business Wire October 28, 2024

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

Business Wire October 21, 2024

BeiGene Highlights Waldenström's Macroglobulinemia Innovation at IWWM 2024

Business Wire October 16, 2024
View More News ››

Opinion & Analysis (NDAQ:BGNE)

BeiGene Shares Up 35% on Amgen's $2.7 Billion Investment and China Partnership

Streetwise Reports November 4, 2019
View More Opinion ››

Bullboard Posts (NDAQ:BGNE)

BeiGene Ltd. (NASDAQ: BGNE) Records 52-Week High Monday Morn

JUST IN: $BGNE BeiGene Ltd. (NASDAQ: BGNE) Records 52-Week High Monday MorningShares of BeiGene, Ltd. (NASDAQ: BGNE) traded at a new 52...
whytestocks - September 30, 2024

BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation

NEWS: $BGNE BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLLDesignation supported by promising safety and...
whytestocks - August 26, 2024

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clin

Just In: $BGNE BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver...
whytestocks - July 23, 2024

BeiGene to Present at the Goldman Sachs 45th Annual Global H

JUST IN: $BGNE BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceBeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160;...
whytestocks - June 4, 2024
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »